Pharmaceutical Commerce

AUGUST 14, 2025

Maintain flexible sourcing strategies, diversify API supply chains, and engage in active government relations to mitigate risks from shifting tariff policies, state-level drug importation programs, and potential federal drug pricing interventions. But by spring 2025, it was reporting near-identical revenue to the previous year.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 29, 2025

July 28, 2025. Accessed July 29, 2025. July 23, 2025. Accessed July 29, 2025. July 28, 2025. Accessed July 29, 2025. How Life Sciences Firms Are Evolving to Navigate Trade, Tariff, and Pricing Turbulence. July 25, 2025. Accessed July 29, 2025. July 25, 2025. Saraceno N.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 16, 2025

I'll explain why this "gold rush" is fraught with peril, from a risk management and insurance perspective. The elephant in the room: The critical absence of FDA approval The fundamental issue with compounded GLP-1s lies in their sidestepping of the rigorous FDA approval process.

Compounding

Pharmaceutical Technology

JULY 7, 2025

July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The collaboration will advance paediatric healthcare by focusing on cell and gene therapies. This alliance seeks to bolster clinical trial capabilities through improved regulatory processes and data governance. Credit: Department of Health Abu Dhabi.

Hospitals

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. wants to ensure the ensuing the US does not lag behind other countries in drug development. RFK Jr did not question their importance, and acknowledged panellists’ calls for faster regulatory processes.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 23, 2025

Many companies have already been in the process of reshoring manufacturing to the United States to avoid the impending tariffs, including AstraZeneca, who plans to invest $50 billion by 2030 in US-based drug manufacturing and R&D, marking its largest single manufacturing investment globally. July 23, 2025. July 22, 2025.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 30, 2025

Robert Barrie June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 1, 2025

Robert Barrie July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shares in NYSE-listed AbbVie closed 1.7% AbbVie’s purchase comes just a few days after the US Food and Drug Administration (FDA) removed an access barrier for currently approved CAR-T therapies, regarded as a boost to the sector’s outlook.

Insurance Coverage and Processing

Pharmaceutical Commerce

JUNE 18, 2025

Click here to view our interactive June 2025 issue! June 18th 2025 Article The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 9, 2025

July 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The JUST-AAV platform features a range of vector types optimised for several target tissues, enhancing the potential of AAV-based gene therapy. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? MAXSHOT.PL via Shutterstock. Give your business an edge with our leading industry insights.

Labelling

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Abigail Beaney July 22, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Sarepta will pause shipments of the therapy to the US while it discusses the therapy with the FDA.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The rare and fatal lysosomal storage disorder primarily impacts the brain.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 1, 2025

1 There are specific diseases—including hemophilia and sickle cell disease (SCD)—that are more widespread in groups enrolled in Medicaid than commercially insured individuals, due to the program’s concentration on children, disabled adults, and those families financially impacted by treatment costs. of average manufacturer price.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 25, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Abigail Beaney July 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The refusal comes based on the Phase III EMBARK trial, which failed to meet its primary endpoint.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 17, 2025

July 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The announcement included updates on Elevidys’ label changes for Duchenne muscular dystrophy treatment. The company anticipates $100m in cost savings by the end of 2025 after accounting for severance costs between $32 and $37m.

Insurance Coverage and Processing

BioPharma Dive

JULY 31, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Vaccines Experts ousted from CDC panel warn of damage to US vaccine policy The 17 advisers fired last month by Robert F. vaccine policymaking process.” Kennedy Jr.

Vaccines

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands.

Vaccines

Big Molecule Watch

AUGUST 25, 2023

The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. There are reports that the White House may announce the list of selected drugs even before that deadline, on Tuesday, August 29 th. Before the IRA, the government could not set prices for any drugs covered by Medicare.

Drug Pricing

Putting Patients First Blog

JANUARY 27, 2025

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.

Insurance Coverage and Processing

Pharmaceutical Commerce

JUNE 13, 2025

Bill Roth Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was the pharmaceutical industry's ability to raise drug prices year after year—enabled by loopholes in PBM contracts—rather than high launch prices alone. to $750 per pill.

Insurance Coverage and Processing